Camelot Portfolios, LLC Pfizer Inc Transaction History

Camelot Portfolios, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $5,607 - $6,571	222 New	222 $6,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $245,074 - $261,273	-7,431 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $1,850 - $2,147	58 Added 0.79%	7,431 $263,000
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $964 - $1,023	-29 Reduced 0.39%	7,373 $267,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $229,462 - $252,778	7,402	7,402 $264,000

3,273

3.72B

77.2M

123M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.